1. Home
  2. CCNE vs REPL Comparison

CCNE vs REPL Comparison

Compare CCNE & REPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CNB Financial Corporation

CCNE

CNB Financial Corporation

HOLD

Current Price

$27.10

Market Cap

736.3M

Sector

Finance

ML Signal

HOLD

Logo Replimune Group Inc.

REPL

Replimune Group Inc.

HOLD

Current Price

$7.04

Market Cap

781.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCNE
REPL
Founded
1865
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
736.3M
781.3M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
CCNE
REPL
Price
$27.10
$7.04
Analyst Decision
Hold
Buy
Analyst Count
1
9
Target Price
$29.00
$12.00
AVG Volume (30 Days)
137.9K
1.3M
Earning Date
01-16-2026
02-11-2026
Dividend Yield
2.66%
N/A
EPS Growth
N/A
N/A
EPS
1.91
N/A
Revenue
$227,923,000.00
N/A
Revenue This Year
$13.84
N/A
Revenue Next Year
$27.68
N/A
P/E Ratio
$14.19
N/A
Revenue Growth
5.27
N/A
52 Week Low
$19.32
$2.68
52 Week High
$28.04
$14.80

Technical Indicators

Market Signals
Indicator
CCNE
REPL
Relative Strength Index (RSI) 58.61 25.98
Support Level $25.72 $7.01
Resistance Level $26.73 $9.41
Average True Range (ATR) 0.56 0.54
MACD 0.02 -0.23
Stochastic Oscillator 87.50 1.81

Price Performance

Historical Comparison
CCNE
REPL

About CCNE CNB Financial Corporation

CNB Financial Corp is providing integrated financial solutions, which create value for both consumers and businesses. These solutions encompass deposit accounts, private banking, real estate, commercial, industrial, residential and consumer loans and lines of credit, credit cards, treasury services, online banking, mobile banking, merchant credit card processing, remote deposit and accounts receivable handling. It derives revenue through the operations as a full-service bank engaging in a full range of banking activities and services, including trust and wealth management services, for individual, business, governmental, and institutional customers. The company branch are located in Pennsylvania, Ohio, New York and Virginia.

About REPL Replimune Group Inc.

Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.

Share on Social Networks: